Evidence map›Paper›PMID 30368740›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study.

Derya Ozturk-Engin, Hakan Erdem, Rodrigo Hasbun, Shu-Hua Wang, Hulya Tireli, Pierre Tattevin, Xavier Argemi, Enora Ouamara-Digue, Andrea Gombos, Botond Lakatos and 22 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. German guideline on neurosyphilis.Neurological research and practice · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 5 countries.

Derya Ozturk-EnginDepartment of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey. dr.deryaengin@gmail.com.
Hakan ErdemPrincipal Coordinator of ID-IRI, Ankara, Turkey.
Rodrigo HasbunDepartment of Infectious Diseases, UT Health McGovern Medical School, Houston, TX, USA.
Shu-Hua WangDivision of Infectious Diseases, Deparment of Internal Medicine, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-8246-1422
Hulya TireliDepartment of Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Pierre TattevinInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Xavier ArgemiDepartment of Infectious Diseases and Clinical Microbiology, Nouvel Hôpital Civil, Strasbourg, France.
Enora Ouamara-DigueInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Andrea GombosDepartment of Infectious Disease and Clinical Microbiology, Saint Laszlo Hospital Budapest, Budapest, Hungary.
Botond LakatosDepartment of Infectious Disease and Clinical Microbiology, Saint Laszlo Hospital Budapest, Budapest, Hungary.
Fatma SırmatelDepartment of Infectious Disease and Clinical Microbiology, Izzet Baysal University School of Medicine, Bolu, Turkey.
Yasemin CagDepartment of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Abdullah Umut PekokDepartment of Infectious Diseases and Clinical Microbiology, Private Erzurum Sifa Hospital, Erzurum, Turkey.
Seniha SenbayrakDepartment of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Ilker Inanç BalkanDepartment of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Marie GhenoInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Nuray UzunDepartment of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Selçuk KayaDepartment of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
Gönül Cicek-SenturkDepartment of Infectious Disease and Clinical Microbiology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Gönül ŞengözDepartment of Infectious Diseases and Clinical Microbiology, Haseki Training and Research Hospital, Istanbul, Turkey.
Recep TekinDepartment of Infectious Diseases and Clinical Microbiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
Mustafa Kemal ÇelenDepartment of Infectious Diseases and Clinical Microbiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
Saygın Nayman-AlpatDepartment of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Pınar ErgenDepartment of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Alper ŞenerDepartment of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey.
Canan AgalarDepartment of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Sükran KöseDepartment of Infectious Diseases and Clinical Microbiology, Tepecik Training and Education Hospital, İzmir, Turkey.
Ahmet Çagkan InkayaDepartment of Infectious Disease and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Figen KaptanDepartment of Infectious Diseases and Clinical Microbiology, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, İzmir, Turkey.
Fahad Al-MajidDepartment of Medicine, Infectious Diseases Division, King Saud University Hospital, Riyadh, Saudi Arabia.
Umit SavasciDepartment of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey.
Haluk VahabogluDepartment of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Hôpital Pontchaillou · FRIstanbul Medeniyet University · TRDicle University · TRFatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRUnified Szent István and Szent László Hospital · HUBolu Abant İzzet Baysal University · TRÇanakkale Onsekiz Mart Üniversitesi · TRDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi · TRErzurum Regional Training and Research Hospital · TREskişehir Osmangazi University · TRGülhane Askerî Tıp Akademisi · TRHacettepe University · TRHaseki Eğitim ve Araştırma Hastanesi · TRHôpital Civil, Strasbourg · FRIstanbul University · TRIzmir Kâtip Çelebi University · TRKaradeniz Technical University · TRKing Saud University · SAŞişli Etfal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurosyphilis (NS) has different clinical manifestations and can appear during any stage of syphilis. We aimed to identify the factors affecting poor outcome in NS patients. Patients with positive cerebrospinal fluid Venereal Disease Research Laboratory test, and positive serological serum treponemal or nontreponemal tests were classified as definite NS. The data of 141 patients with definite NS were submitted from 22 referral centers. Asymptomatic NS, syphilitic meningitis, meningovascular syphilis, tabes dorsalis, general paresis, and taboparesis were detected in 22 (15.6%), 67 (47.5%), 13 (9.2%), 10 (7%), 13 (9.2%), and 16 patients (11.3%), respectively. The number of HIV-positive patients was 43 (30.4%). The most common symptoms were headache (n = 55, 39%), fatigue (n = 52, 36.8%), and altered consciousness (50, 35.4%). Tabetic symptoms were detected in 28 (19.8%), paretic symptoms in 32 (22.6%), and vascular symptoms in 39 patients (27.6%). Eye involvement was detected in 19 of 80 patients (23.7%) who underwent eye examination and ear involvement was detected in eight of 25 patients (32%) who underwent ear examination. Crystallized penicillin was used in 109 (77.3%), procaine penicillin in seven (4.9%), ceftriaxone in 31 (21.9%), and doxycycline in five patients (3.5%). According to multivariate regression analysis, while headache was a protective factor in NS patients, double vision was significantly associated to poor outcome. We concluded that double vision indicated unfavorable outcome among NS patients. A high clinical suspicion is needed for the diagnosis NS. As determined in our study, the presence of headache in syphilitic patients can help in early diagnosis of central nervous system disease.

Indexed as

AdultAnti-Bacterial AgentsCohort StudiesDiplopiaFemaleHeadacheHumansLength of StayMaleMiddle AgedNeurosyphilisTreatment OutcomeAnti-Bacterial AgentsCerebrospinal fluidNeurosyphilisOutcomeSyphilisVDRL

Identifiers

PMID30368740
OpenAlexW2898456102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.